Company Overview
Snapshot
Founded in June 2014 by Yochi Slonim and Zeev Smilanski, Anima Biotech operates with 51–200 employees. The company has secured $30 million in total capital across one funding round. In January 2023, Anima Biotech announced a collaboration with AbbVie for the discovery and development of mRNA biology modulators.
Business overview
Anima Biotech is a biotechnology company focused on the discovery of small-molecule mRNA drugs. The company utilizes its proprietary mRNA Lightning platform, which integrates high-scale phenotypic screening with AI-driven MOAi technology to elucidate the mechanism of action of active molecules. This approach enables the development of a broad pipeline across various therapeutic areas, including fibrosis, oncology, and neuroscience. Anima Biotech serves the pharmaceutical industry through strategic collaborations, developing novel therapies for diseases such as lung fibrosis, Alzheimer's disease, and pain.
Strategic signal
Anima Biotech's strategic collaboration with AbbVie, announced in January 2023, for the discovery and development of mRNA biology modulators against oncology and immunology targets, signals significant validation of its mRNA Lightning platform. This partnership demonstrates the pharmaceutical industry's growing interest in leveraging AI-driven phenotypic screening for novel drug discovery, positioning Anima Biotech as a key player in advancing mRNA-targeted therapeutics.
Log in to access full profile ›Company Intelligence Q&A
- When was Anima Biotech founded?
- Anima Biotech was founded in June 2014.
- What was a significant recent partnership for Anima Biotech?
- In January 2023, Anima Biotech announced a collaboration with AbbVie for the discovery and development of mRNA biology modulators against oncology and immunology targets.
- Has Anima Biotech achieved any milestones in its collaborations?
- In July 2022, Anima Biotech achieved a milestone in its collaboration with Takeda Pharmaceuticals.
- What was the outcome of the collaboration with Eli Lilly?
- In November 2018, Eli Lilly & Co. and Anima Biotech won the US Deal of the Year Award at the LifeStars Awards 2018 for their collaboration.